• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内出血的治疗和再生管理的当代综述。

A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.

机构信息

Punjab Medical College, University of Health Science, Faisalabad, Pakistan.

Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, Texas, USA.

出版信息

Ann Clin Transl Neurol. 2021 Nov;8(11):2211-2221. doi: 10.1002/acn3.51443. Epub 2021 Oct 14.

DOI:10.1002/acn3.51443
PMID:34647437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607450/
Abstract

Intracerebral hemorrhage (ICH) remains a common and debilitating form of stroke. This neurological emergency must be diagnosed and treated rapidly yet effectively. In this article, we review the medical, surgical, repair, and regenerative treatment options for managing ICH. Topics of focus include the management of blood pressure, intracranial pressure, coagulopathy, and intraventricular hemorrhage, as well as the role of surgery, regeneration, rehabilitation, and secondary prevention. Results of various phase II and III trials are incorporated. In summary, ICH patients should undergo rapid evaluation with neuroimaging, and early interventions should include systolic blood pressure control in the range of 140 mmHg, correction of coagulopathy if indicated, and assessment for surgical intervention. ICH patients should be managed in dedicated neurosurgical intensive care or stroke units where continuous monitoring of neurological status and evaluation for neurological deterioration is rapidly possible. Extravasation of hematoma may be helpful in patients with intraventricular extension of ICH. The goal of care is to reduce mortality and enable multimodal rehabilitative therapy.

摘要

脑出血(ICH)仍然是一种常见且使人虚弱的中风形式。这种神经急症必须迅速而有效地进行诊断和治疗。在本文中,我们回顾了用于管理 ICH 的医学、外科、修复和再生治疗选择。重点关注的主题包括血压、颅内压、凝血障碍和脑室出血的管理,以及手术、再生、康复和二级预防的作用。已纳入各种 II 期和 III 期试验的结果。总之,ICH 患者应进行神经影像学快速评估,早期干预措施应包括将收缩压控制在 140mmHg 范围内,如果有指征,应纠正凝血障碍,并评估手术干预的可能性。ICH 患者应在专门的神经外科重症监护病房或卒中单元中进行管理,以便能够快速连续监测神经状态并评估神经恶化情况。血肿外渗在 ICH 伴有脑室延伸的患者中可能有帮助。治疗的目标是降低死亡率并使多模式康复治疗成为可能。

相似文献

1
A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.颅内出血的治疗和再生管理的当代综述。
Ann Clin Transl Neurol. 2021 Nov;8(11):2211-2221. doi: 10.1002/acn3.51443. Epub 2021 Oct 14.
2
The acute management of intracerebral hemorrhage: a clinical review.脑出血的急性治疗:临床综述。
Anesth Analg. 2010 May 1;110(5):1419-27. doi: 10.1213/ANE.0b013e3181d568c8. Epub 2010 Mar 23.
3
Clinical practice guidelines in intracerebral haemorrhage.脑出血临床实践指南。
Neurologia. 2013 May;28(4):236-49. doi: 10.1016/j.nrl.2011.03.010. Epub 2011 May 13.
4
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies.急性脑出血中神经外科利用和结局的实践模式:急性脑出血试验 1 和 2 研究中的强化降压治疗。
Neurosurgery. 2017 Dec 1;81(6):980-985. doi: 10.1093/neuros/nyx129.
5
Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.争分夺秒:克服抗凝相关脑出血管理中的挑战。
J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm.
6
The clinical management of acute intracerebral hemorrhage.急性脑出血的临床管理
Expert Rev Neurother. 2015;15(12):1421-32. doi: 10.1586/14737175.2015.1113876. Epub 2015 Nov 13.
7
[Management of intracerebral hemorrhage: can we still learn something?].[脑出血的管理:我们还能学到什么?]
Nervenarzt. 2012 Dec;83(12):1569-74. doi: 10.1007/s00115-012-3531-8.
8
Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes.INTERACT2脑出血血压治疗试验中患者的重症监护病房收治情况:特征、预测因素及结局
Neurocrit Care. 2017 Jun;26(3):371-378. doi: 10.1007/s12028-016-0365-4.
9
[New methods of intensive therapy in stroke: hemicraniectomy in patients with complete middle cerebral artery infarction and treatment of intracerebral and intraventricular hemorrhage with urokinase].[中风强化治疗的新方法:大脑中动脉完全梗死患者的去骨瓣减压术及尿激酶治疗脑内和脑室内出血]
Ideggyogy Sz. 2002 Mar 20;55(3-4):118-27.
10
Intracerebral hemorrhage.脑出血
Semin Neurol. 2008 Nov;28(5):657-67. doi: 10.1055/s-0028-1105974. Epub 2008 Dec 29.

引用本文的文献

1
Global, regional, and national epidemiology of Intracerebral Hemorrhage among women of childbearing age (1990-2021): incidence, mortality, DALYs, and risk factor analysis.1990 - 2021年育龄女性脑内出血的全球、区域和国家流行病学:发病率、死亡率、伤残调整生命年及风险因素分析
Front Neurol. 2025 Aug 5;16:1602507. doi: 10.3389/fneur.2025.1602507. eCollection 2025.
2
Dynamic changes in chromatin accessibility within one month of mouse intracerebral hemorrhage.小鼠脑出血后一个月内染色质可及性的动态变化。
iScience. 2025 Jun 2;28(7):112815. doi: 10.1016/j.isci.2025.112815. eCollection 2025 Jul 18.
3
The prognostic value of red blood cell distribution width for mortality in intracranial hemorrhage: A systematic review and meta-analysis.红细胞分布宽度对颅内出血死亡率的预后价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Mar 14;104(11):e41487. doi: 10.1097/MD.0000000000041487.
4
GFAP point-of-care measurement for prehospital diagnosis of intracranial hemorrhage in acute coma.用于急性昏迷患者院前颅内出血诊断的 GFAP 即时检测。
Crit Care. 2024 Apr 5;28(1):109. doi: 10.1186/s13054-024-04892-5.
5
Exploring the Ferroptosis Mechanism of Zhilong Huoxue Tongyu Capsule for the Treatment of Intracerebral Hemorrhage Based on Network Pharmacology and Validation.基于网络药理学和实验验证探索蛭龙活血通瘀胶囊治疗脑出血的铁死亡机制
Evid Based Complement Alternat Med. 2022 Sep 25;2022:5033135. doi: 10.1155/2022/5033135. eCollection 2022.
6
Activation of LRP6 with HLY78 Attenuates Oxidative Stress and Neuronal Apoptosis via GSK3/Sirt1/PGC-1 Pathway after ICH.载脂蛋白 LRP6 激动剂 HLY78 通过 GSK3/Sirt1/PGC-1 通路减轻 ICH 后氧化应激和神经元凋亡。
Oxid Med Cell Longev. 2022 Apr 4;2022:7542468. doi: 10.1155/2022/7542468. eCollection 2022.

本文引用的文献

1
Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage.自发性脑出血后口服抗凝治疗的恢复
Neurol Res Pract. 2019 May 10;1:12. doi: 10.1186/s42466-019-0018-0. eCollection 2019.
2
Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.全球、区域和国家特定缺血性卒中、脑出血和蛛网膜下腔出血负担:2017 年全球疾病负担研究的系统分析。
Neuroepidemiology. 2020;54(2):171-179. doi: 10.1159/000506396. Epub 2020 Feb 20.
3
Surgery for spontaneous intracerebral hemorrhage.自发性脑出血的外科治疗。
Crit Care. 2020 Feb 7;24(1):45. doi: 10.1186/s13054-020-2749-2.
4
Factors Associated with Inpatient Mortality after Intracerebral Hemorrhage: Updated Information from the United States Nationwide Inpatient Sample.脑出血后住院死亡率的相关因素:来自美国全国住院样本的最新信息。
J Stroke Cerebrovasc Dis. 2020 Mar;29(3):104583. doi: 10.1016/j.jstrokecerebrovasdis.2019.104583. Epub 2019 Dec 18.
5
Racial/ethnic disparities in the risk of intracerebral hemorrhage recurrence.种族/民族差异与脑出血复发风险。
Neurology. 2020 Jan 21;94(3):e314-e322. doi: 10.1212/WNL.0000000000008737. Epub 2019 Dec 12.
6
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.静脉内骨髓单核细胞治疗急性缺血性脑卒中:一项 I 期临床试验的安全性、可行性和效果大小。
Stem Cells. 2019 Nov;37(11):1481-1491. doi: 10.1002/stem.3080. Epub 2019 Sep 17.
7
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.甲磺酸去铁胺治疗脑出血患者的研究(i-DEF):一项多中心、随机、安慰剂对照、双盲的 2 期临床试验。
Lancet Neurol. 2019 May;18(5):428-438. doi: 10.1016/S1474-4422(19)30069-9. Epub 2019 Mar 18.
8
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.非维生素 K 拮抗剂口服抗凝剂与华法林在伴有脑出血的心房颤动患者中的比较。
Stroke. 2019 Apr;50(4):939-946. doi: 10.1161/STROKEAHA.118.023797.
9
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.微创血肿清除术与溶栓治疗脑出血的疗效和安全性(MISTIE III):一项随机、对照、开放标签、盲终点 3 期试验。
Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7.
10
Serum magnesium level and hematoma expansion in patients with intracerebral hemorrhage.血清镁水平与脑出血患者的血肿扩大。
J Neurol Sci. 2019 Mar 15;398:39-44. doi: 10.1016/j.jns.2019.01.027. Epub 2019 Jan 16.